참고문헌
- Bogdanova N, Feshchenko S, Schurmann P, et al (2008a). Nijmegen Breakage Syndrome mutations and risk of breast cancer. Int J Cancer, 122, 802-6. https://doi.org/10.1002/ijc.23168
- Bogdanova N, Schurmann P, Waltes R, et al (2008b). NBS1 variant I171V and breast cancer risk. Breast Cancer Res Treat, 112, 75-9. https://doi.org/10.1007/s10549-007-9820-4
- Buslov KG, Iyevleva AG, Chekmariova EV, et al (2005). NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia. Int J Cancer, 114, 585-9. https://doi.org/10.1002/ijc.20765
- Carlomagno F, Chang-Claude J, Dunning AM, et al (1999). Determination of the frequency of the common 657Del5 Nijmegen breakage syndrome mutation in the German population: no association with risk of breast cancer. Genes Chromosomes Cancer, 25, 393-5. https://doi.org/10.1002/(SICI)1098-2264(199908)25:4<393::AID-GCC12>3.0.CO;2-8
- DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. https://doi.org/10.1016/0197-2456(86)90046-2
- Desjardins S, Beauparlant JC, Labrie Y, et al (2009). Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer. BMC Cancer, 9, 181. https://doi.org/10.1186/1471-2407-9-181
- Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. https://doi.org/10.1136/bmj.315.7109.629
- Gorski B, Cybulski C, Huzarski T, et al (2005). Breast cancer predisposing alleles in Poland. Breast Cancer Res Treat, 92, 19-24. https://doi.org/10.1007/s10549-005-1409-1
- Gorski B, Debniak T, Masojc B, et al (2003). Germline 657del5 mutation in the NBS1 gene in breast cancer patients. Int J Cancer, 106, 379-81. https://doi.org/10.1002/ijc.11231
- Kanka C, Brozek I, Skalska B, et al (2007). Germline NBS1 mutations in families with aggregation of Breast and/or ovarian cancer from north-east Poland. Anticancer Res, 27, 3015-8.
- Lau J, Ioannidis JP, and Schmid CH (1997). Quantitative synthesis in systematic reviews. Ann Intern Med, 127, 820-6. https://doi.org/10.7326/0003-4819-127-9-199711010-00008
- Mantel N, and Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
- Mosor M, Ziolkowska I, Pernak-Schwarz M, et al (2006). Association of the heterozygous germline I171V mutation of the NBS1 gene with childhood acute lymphoblastic leukemia. Leukemia, 20, 1454-6. https://doi.org/10.1038/sj.leu.2404285
- Nowak J, Mosor M, Ziolkowska I, et al (2008). Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours. Eur J Cancer, 44, 627-30. https://doi.org/10.1016/j.ejca.2008.01.006
- Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
- Pharoah PD, Dunning AM, Ponder BA, et al (2004). Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer, 4, 850-60. https://doi.org/10.1038/nrc1476
- Roznowski K, Januszkiewicz-Lewandowska D, Mosor M, et al (2008). I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer. Breast Cancer Res Treat, 110, 343-8. https://doi.org/10.1007/s10549-007-9734-1
- Steffen J, Nowakowska D, Niwinska A, et al (2006). Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland. Int J Cancer, 119, 472-5. https://doi.org/10.1002/ijc.21853
- Steffen J, Varon R, Mosor M, et al (2004). Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland. Int J Cancer, 111, 67-71. https://doi.org/10.1002/ijc.20239
- Varon R, Seemanova E, Chrzanowska K, et al (2000). Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slav populations. Eur J Hum Genet, 8, 900-902. https://doi.org/10.1038/sj.ejhg.5200554
- Ziolkowska I, Mosor M, Wierzbicka M, et al (2007). Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene. Cancer Sci, 98, 1701-5. https://doi.org/10.1111/j.1349-7006.2007.00594.x
피인용 문헌
- Rare key functional domain missense substitutions in MRE11A, RAD50, and NBNcontribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study vol.16, pp.3, 2014, https://doi.org/10.1186/bcr3669
- Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment vol.32, pp.19, 2014, https://doi.org/10.1200/JCO.2013.53.6607
- Genetic risk assessment and prevention: the role of genetic testing panels in breast cancer vol.15, pp.11, 2015, https://doi.org/10.1586/14737140.2015.1090879
- Estimating cumulative risks for breast cancer for carriers of variants in uncommon genes vol.15, pp.3, 2016, https://doi.org/10.1007/s10689-016-9896-2
- Growing recognition of the role for rare missense substitutions in breast cancer susceptibility vol.8, pp.4, 2014, https://doi.org/10.2217/bmm.13.143
- A Clinical Decision Support Tool to Predict Cancer Risk for Commonly Tested Cancer-Related Germline Mutations vol.27, pp.5, 2018, https://doi.org/10.1007/s10897-018-0238-4